VALENCIA, Calif., Feb. 15, 2017 /PRNewswire/ -- Bioness, Inc., the leading provider of cutting-edge, clinically supported rehabilitation therapies, today announced it will feature its full suite of innovative technologies at the American Physical Therapy Association's (APTA) Combined Sections Meeting (CSM) from February 16-18 in San Antonio, TX. Bioness clinical solutions are focused on helping clinicians improve outcomes in the value-based economy. Attendees will have the chance to experience Bioness implantable and external neuromodulation systems, robotic systems and software based therapy programs at booths #1319 and #1261.
Innovative solutions debuting at APTA-CSM include:
"We are expanding our leadership position in rehabilitation by introducing several groundbreaking technologies at APTA-CSM," said Todd Cushman, President and CEO of Bioness. "The most notable innovation is the L300 Go which is the first commercial FES technology to incorporate 3D motion detection and multi-channel stimulation to improve patient mobility and enhance treatment efficiency. With the addition of L300 Go, BITS Bedside and Vector with Intuitive Body Weight Support, we have enhanced our position as the technological leader in rehabilitation so that we can expand therapeutic interventions and further help the patients we serve. We look forward to sharing these new innovations and our new augmented reality experience with the APTA-CSM attendees."
Bioness has been an industry leader supporting the efforts of skilled acute, inpatient and outpatient practices for more than a decade. At this year's APTA-CSM meeting, Bioness is pleased to introduce four clinical innovations as well as showcase the Bioness Technology Exhibit.
L300 Go System™
The recently FDA cleared L300 Go™ System is the first functional electrical stimulation (FES) device to provide 3D motion detection of gait events using a 3-axis gyroscope and accelerometer technology. Patients facing mobility challenges due to neurological injury or disease, such as stroke, multiple sclerosis, traumatic brain injury or spinal cord injury, have less control over their lower extremity muscles which increases fall risk and reduces social participation. By monitoring patient movement in all three planes of motion and deploying stimulation to provide ankle dorsiflexion and knee flexion or extension precisely when needed during the gait cycle, Bioness is further improving therapist efficiency in detecting a gait event. The L300 Go now includes the myBioness™ mobile iOS application to keep home users engaged in the rehabilitation process and motivated to meet recovery goals. For the first time, CSM attendees will be able to experience an augmented reality demonstration of the new L300 Go and its advancements, and learn more about how the device can improve hemiparetic gait.
BITS Bedside™
Most rehabilitation activities are designed to be performed from a standing position, however, many rehab patients are confined to their beds for medical reasons. To help tackle this challenge, Bioness will be unveiling BITS Bedside, a new clinical solution that will allow clinicians to engage rehab patients that are unable to leave their bed or controlled rehabilitation space. Clinicians can challenge patients with physical and cognitive programs and assessments. The new technology also provides the ability to track and document progress, with the goal of keeping patients engaged during this important phase of care.
Vector Gait and Safety System with Intuitive Body Weight Support
The Vector System with Intuitive Body Weight Support is Simply Smarter™. Intuitive Body Weight Support is a revolutionary innovation that allows patients to further the real-world experience in the clinic to properly prepare them for the community. Clinicians maintain unparalleled safety and product for their patients while permitting an unparalleled level of activity and interaction. The Vector Gait and Safety System is designed to improve patient mobility and functional independence while increasing patient and clinician safety. Parameters are based on patient ability or activity which helps gain confidence and allows clinicians to get more creative and aggressive during treatment. In addition, clinicians can run, record and document standardized tests to measure patient outcomes within the Vector software interface.
StimRouter Neuromodulation System™ for Chronic Peripheral Pain
With an estimated 100 million people suffering from chronic pain, contributing more than $280 billion in annual costs to the U.S. healthcare system, there's never been a greater need for innovative pain management options.[1] Specific to rehabilitation, shoulder pain is a common disability resulting from a central nervous system trauma (e.g. stroke). This pain traditionally originates at the axillary nerve, a peripheral nerve in the upper arm, and has been reported to occur in up to 85% of stroke survivors.[2] StimRouter is designed to target pain at the point of origin, minimize long-term healthcare costs and may provide pain relief when other treatments such as medications and injections have limited effect.[3]
Experience Bioness First Hand
Visit Bioness at APTA-CSM at booths #1319 and #1261. Be among the first to experience Bioness solutions in gait training, pain management and software therapy programs.
About Bioness, Inc.
Bioness is the leading provider of innovative technologies helping people regain mobility and independence. Bioness solutions include implantable and external neuromodulation systems, robotic systems and software based therapy programs providing functional and therapeutic benefits for individuals affected by pain, central nervous system disorders and orthopedic injuries. Currently, Bioness offers six medical devices within its commercial portfolio which are distributed and sold on five continents and in over 25 countries worldwide. Bioness innovations have been implemented in the most prestigious and well-respected institutions around the globe with 17 of the top 20 rehabilitation hospitals in the United States currently using one or more Bioness solution. Bioness has a singular focus on aiding large, underserved customer groups with innovative, evidence-based solutions and we will continue to develop and make commercially available new products that address the growing and changing needs of our customers. Individual results vary. Consult with a qualified physician to determine if this product is right for you. Contraindications, adverse reactions and precautions are available online at www.bioness.com.
Media Relations Contact Information
Next Step Communications
bioness@nextstepcomms.com
781.326.1741
Bioness®, BITS®, H200®, L300®, L300 Plus®, L300 Go™, StimRouter™ and Vector Gait and Safety System® are trademarks of Bioness, Inc. | www.bioness.com | Rx Only for applicable products.
[1] Institute of Medicine (US). Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education and Research. 2011. The National Academies.
[2] Van Ouwenaller, C. et al. 1986. Archives of Physical Medicine and Rehabilitation. 67, 23–26.
[3] Deer T, et al. 2016. Neuromodulation. 19:91-100.
SOURCE Bioness, Inc.